Impact of clinical fractures on health-related quality of life is dependent on time of assessment since fracture: results from the FREEDOM trial

Abstract

Double-blind, randomised, controlled study with denosumab in treatment of postmenopausal osteoporosis. Based on quality of life outcome measures.Results of study FREEDOM.

Keywords

• osteoporosis
• denosumab
• therapy